Trials / Completed
CompletedNCT02330991
A Trial of One-week on/One-week Off Temozolomide Versus Continuous Dose-Intense Temozolomide in Patients With Glioblastoma Multiforme at First Relapse
- Status
- Completed
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 204 (actual)
- Sponsor
- Beijing Sanbo Brain Hospital · Academic / Other
- Sex
- All
- Age
- 18 Years – 75 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to evaluate the clinical benefit and safety of two different Dose-Intense temozolomide regimens（one-week on/one-week off regimen versus continuous dose-intense regimen）in patients with glioblastoma at first relapse.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Temozolomide |
Timeline
- Start date
- 2015-01-01
- Primary completion
- 2020-03-01
- Completion
- 2020-09-01
- First posted
- 2015-01-05
- Last updated
- 2023-07-24
Source: ClinicalTrials.gov record NCT02330991. Inclusion in this directory is not an endorsement.